# A 6-Month Extension Study of OTO-104 in Meniere's Disease

> **NCT02706730** · PHASE3 · TERMINATED · sponsor: **Otonomy, Inc.** · enrollment: 189 (actual)

## Conditions studied

- Meniere's Disease

## Interventions

- **DRUG:** OTO-104

## Key facts

- **NCT ID:** NCT02706730
- **Lead sponsor:** Otonomy, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 189 (ACTUAL)
- **Why stopped:** Negative Efficacy Results from the recently completed Phase 3 study 104-201506
- **Last updated:** 2022-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02706730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02706730, "A 6-Month Extension Study of OTO-104 in Meniere's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02706730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*